305 related articles for article (PubMed ID: 37061693)
21. Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock.
Stahl K; Schmidt JJ; Seeliger B; Schmidt BMW; Welte T; Haller H; Hoeper MM; Budde U; Bode C; David S
Crit Care; 2020 Mar; 24(1):71. PubMed ID: 32122366
[TBL] [Abstract][Full Text] [Related]
22. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M
Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449
[TBL] [Abstract][Full Text] [Related]
23. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
24. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
25. A trial to determine whether septic shock-reversal is quicker in pediatric patients randomized to an early goal-directed fluid-sparing strategy versus usual care (SQUEEZE): study protocol for a pilot randomized controlled trial.
Parker MJ; Thabane L; Fox-Robichaud A; Liaw P; Choong K;
Trials; 2016 Nov; 17(1):556. PubMed ID: 27876084
[TBL] [Abstract][Full Text] [Related]
26. Survival Benefits of Therapeutic Plasma Exchange in Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis.
Lee OPE; Kanesan N; Leow EH; Sultana R; Chor YK; Gan CS; Lee JH
J Intensive Care Med; 2023 Jul; 38(7):598-611. PubMed ID: 37097910
[TBL] [Abstract][Full Text] [Related]
27. Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial.
Pettilä V; Merz T; Wilkman E; Perner A; Karlsson S; Lange T; Hästbacka J; Hjortrup PB; Kuitunen A; Jakob SM; Takala J
Trials; 2016 Aug; 17():384. PubMed ID: 27484695
[TBL] [Abstract][Full Text] [Related]
28. High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: a multicenter randomized controlled trial.
Chung KK; Coates EC; Smith DJ; Karlnoski RA; Hickerson WL; Arnold-Ross AL; Mosier MJ; Halerz M; Sprague AM; Mullins RF; Caruso DM; Albrecht M; Arnoldo BD; Burris AM; Taylor SL; Wolf SE;
Crit Care; 2017 Nov; 21(1):289. PubMed ID: 29178943
[TBL] [Abstract][Full Text] [Related]
29. Remote ischemic conditioning in septic shock: the RECO-Sepsis randomized clinical trial.
Cour M; Klouche K; Souweine B; Quenot JP; Schwebel C; Perinel S; Amaz C; Buisson M; Ovize M; Mewton N; Argaud L;
Intensive Care Med; 2022 Nov; 48(11):1563-1572. PubMed ID: 36100725
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW;
Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
Hosogaya N; Miyazaki T; Fukushige Y; Takemori S; Morimoto S; Yamamoto H; Hori M; Kurokawa T; Kawasaki Y; Hanawa M; Fujii Y; Hanaoka H; Iwami S; Watashi K; Yamagoe S; Miyazaki Y; Wakita T; Izumikawa K; Yanagihara K; Mukae H; Kohno S;
Trials; 2021 Apr; 22(1):309. PubMed ID: 33910617
[TBL] [Abstract][Full Text] [Related]
32. The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis.
Rimmer E; Houston BL; Kumar A; Abou-Setta AM; Friesen C; Marshall JC; Rock G; Turgeon AF; Cook DJ; Houston DS; Zarychanski R
Crit Care; 2014 Dec; 18(6):699. PubMed ID: 25527094
[TBL] [Abstract][Full Text] [Related]
33. Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.
Lipcsey M; Tenhunen J; Sjölin J; Frithiof R; Bendel S; Flaatten H; Kawati R; Kuitunen A; Tønnessen TI; Rubertsson S
Trials; 2016 Dec; 17(1):587. PubMed ID: 27931259
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of 4-hour rescue therapeutic plasma exchange in severe septic shock patients.
Ahmed RM; Soliman AR; Yousry A; Marzouk K; Faris F
Rom J Intern Med; 2020 Jun; 58(2):75-80. PubMed ID: 31955149
[TBL] [Abstract][Full Text] [Related]
35. Combination therapy of vitamin C and thiamine for septic shock in a multicentre, double-blind, randomized, controlled study (ATESS): study protocol for a randomized controlled trial.
Hwang SY; Park JE; Jo IJ; Kim S; Chung SP; Kong T; Shin J; Lee HJ; You KM; Jo YH; Kim D; Suh GJ; Kim T; Kim WY; Kim YJ; Ryoo SM; Choi SH; Shin TG;
Trials; 2019 Jul; 20(1):420. PubMed ID: 31296251
[TBL] [Abstract][Full Text] [Related]
36. Optimal target blood pressure in elderly with septic shock (OPTPRESS) trial: study protocol for a randomized controlled trial.
Endo A; Yamakawa K; Tagami T; Umemura Y; Takahashi K; Nagasawa H; Araki Y; Kojima M; Sera T; Yagi M; Yamamoto R; Takahashi J; Nakane M; Takeda C; Narita C; Kazuma S; Okura H; Takahashi H; Wada T; Tahara S; Matsuoka A; Masaki T; Shiraishi A; Shimoyama K; Yokokawa Y; Nakamura R; Sageshima H; Yanagida Y; Takahashi K; Otomo Y
Trials; 2022 Sep; 23(1):799. PubMed ID: 36153530
[TBL] [Abstract][Full Text] [Related]
37. Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial.
Whitehouse T; Hossain A; Perkins GD; Gordon AC; Bion J; Young D; McAuley D; Singer M; Lord J; Gates S; Veenith T; MacCallum NS; Yeung J; Innes R; Welters I; Boota N; Skilton E; Ghuman B; Hill M; Regan SE; Mistry D; Lall R;
JAMA; 2023 Nov; 330(17):1641-1652. PubMed ID: 37877587
[TBL] [Abstract][Full Text] [Related]
38. A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
Sharma A; Sharma C; Raina S; Singh B; Dadhwal DS; Dogra V; Gupta S; Bhandari S; Sood V
Trials; 2021 Jul; 22(1):451. PubMed ID: 34266452
[TBL] [Abstract][Full Text] [Related]
39. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of iloprost in patients with septic shock-induced endotheliopathy-Protocol for the multicenter randomized, placebo-controlled, blinded, investigator-initiated trial.
Bestle MH; Clausen NE; Søe-Jensen P; Kristiansen KT; Lange T; Johansson PI; Stensballe J; Perner A
Acta Anaesthesiol Scand; 2020 May; 64(5):705-711. PubMed ID: 31950481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
